Exercise-induced cardiac troponin T release in veteran athletes recovered from COVID-19

Le résumé fourni par la source

Coronavirus disease 2019 (COVID-19) can cause myocardial injury as evidenced by increased resting cardiac troponin (cTn) concentrations.1 Stressing the heart with exercise potentially increases sensitivity of detecting myocardial injury, as evidenced by exercise-induced cTn elevations.2 Hence, exercise might reveal myocardial vulnerability, which could remain unrecognized under resting conditions. Therefore, we assessed exercise-induced high-sensitivity cardiac troponin T (hs-cTnT) release in middle-aged athletes recovered from COVID-19 and compared their response to matched controls. We hypothesized that athletes who recovered from COVID-19 would have greater exercise-induced cTn release compared to controls. We recruited 32 male recreational endurance athletes aged 56 (interquartile range: 54–58) years from an ongoing cohort study3 and via a newsletter from a local mass-participation running event. Eligible participants were contacted via e-mail and/or phone and invited to participate in this laboratory study. Participants were allocated to a COVID-19 group (n = 16) or control group (n = 16) and matched for age, sex, and cardiovascular risk factors (i.e. hypertension, hypercholesterolaemia, diabetes mellitus, family history of cardiovascular disease, and smoking status) at a group level. All COVID-19 participants had a positive polymerase chain reaction (PCR) test of a nasopharyngeal sample for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within 6 months prior to study participation. Serology testing was not performed for the controls, but they had no signs or symptoms of COVID-19 nor a lifetime positive PCR prior to study participation. Participants performed a standardized yet personalized exercise test on a stationary bike (Lode Excalibur Sport, Groningen, Netherlands), consisting of a 30-min warm up with a gradually increasing workload, until they reached a stable heart rate at 70% of their expected maximum heart rate. Maximal heart rate was obtained from training data, a previously performed exercise test or estimated based on age (208 − 0.7 × Age).4 When 70% of maximum heart rate was reached, the workload was kept stable until 30 min of warming up had passed. Thereafter, workload increased by 5% at every 3 min until volitional exhaustion was reached, defining the end of the exercise test. During and following the exercise test, physiological measurements (i.e. heart rate, blood pressure, peripheral oxygen saturation, electrocardiography, perceived exercise intensity, lactate) were obtained. Blood samples were collected at the following 7 time points: baseline (before exercise), after the first 30 min of exercise and at 0, 30, 60, 120, and 180 min after exercise cessation. High-sensitivity cardiac troponin T concentrations were measured (Cobas 6000 analyzer, Troponin T Gen 5 STAT, Roche Diagnostics). An overview of the study protocol is presented in Supplementary material online, Figure S1. The Medical Research Ethical Committee region Arnhem-Nijmegen approved this study (NL74326.091.20) and all participants provided written informed consent. Due to the skewed nature of hs-cTnT concentrations, data were logarithmically transformed prior to analyses. Data are presented as mean ± standard deviation, median (interquartile range), or frequency (%). A mixed model analysis using random intercepts was performed to compare time-dependent changes in outcome measures between groups. All statistical tests were two-sided and P-values below 0.05 were considered as statistically significant. Participant characteristics were comparable between groups (Table 1). Median time since COVID-19 diagnosis was 175 (166–183) days. One month after the onset of COVID-19 infection, 7 athletes (43.8%) did not exercise at all and 9 athletes (56.3%) exercised less due to persisting symptoms. The exercise test lasted 72.1 (63.5–84.1) min with a peak heart rate of 167 ± 14 b.p.m. (97.1 ± 6.1% of HRmax), which did not differ between groups (Figure 1). Maximal workload was significantly lower for the COVID-19 vs. control group (189 ± 39 W vs. 224 ± 38 W, P = 0.016). Exercise-induced changes in hs-cTnT concentrations and physiological changes during exercise. No differences in changes in hs-cTnT concentrations were observed over time between the COVID-19 and control group (P = 0.73), but average and peak hs-cTnT concentrations were significantly lower in the COVID-19 vs. control group (P = 0.045) (A). Changes in individual hs-cTnT concentrations for the COVID-19 group (in red, B) and the control group (in blue, C) over time, with the group median in black. Time-dependent changes in blood pressure (D), heart rate (E), and percentage of maximal heart rate (F) for the COVID-19 group (in red) and control group (in blue). % of HRmax, percentage of expected maximal heart rate; HR, heart rate; hs-cTnT, high-sensitivity cardiac troponin T; SBP/DBP, systolic/diastolic blood pressure, respectively; URL, 99% upper reference limit of 14.0 ng/L. hs-cTnT concentrations are presented at baseline (B0), after 30 min of warm up exercise (E30), and at t = 0, t = 30, t = 60, t = 120, and t = 180 min after exercise cessation (P0, P30, P60, P120, and P180, respectively). Physiological data are presented at screening (Scr), at 0%, 20%, 40%, 60%, 80%, and 100% completion of the exercise test, and at t = 2, t = 30, t = 60, t = 120, and t = 180 min after exercise cessation. Exercise-induced changes in hs-cTnT concentrations and physiological changes during exercise. No differences in changes in hs-cTnT concentrations were observed over time between the COVID-19 and control group (P = 0.73), but average and peak hs-cTnT concentrations were significantly lower in the COVID-19 vs. control group (P = 0.045) (A). Changes in individual hs-cTnT concentrations for the COVID-19 group (in red, B) and the control group (in blue, C) over time, with the group median in black. Time-dependent changes in blood pressure (D), heart rate (E), and percentage of maximal heart rate (F) for the COVID-19 group (in red) and control group (in blue). % of HRmax, percentage of expected maximal heart rate; HR, heart rate; hs-cTnT, high-sensitivity cardiac troponin T; SBP/DBP, systolic/diastolic blood pressure, respectively; URL, 99% upper reference limit of 14.0 ng/L. hs-cTnT concentrations are presented at baseline (B0), after 30 min of warm up exercise (E30), and at t = 0, t = 30, t = 60, t = 120, and t = 180 min after exercise cessation (P0, P30, P60, P120, and P180, respectively). Physiological data are presented at screening (Scr), at 0%, 20%, 40%, 60%, 80%, and 100% completion of the exercise test, and at t = 2, t = 30, t = 60, t = 120, and t = 180 min after exercise cessation. Baseline characteristics and exercise test performance, total and split for different study groups %Hrmax, percentage of expected maximal heart rate; BMI, body mass index; CV, cardiovascular; HR, heart rate; hs-cTnT, high-sensitive cardiac troponin T; LoD, limit of detection; Maximal W/kg, maximal workload per kilogram of body weight; RPE, rating of perceived exertion scale (6 = very, very light–20 = maximal exertion); URL, 99% upper reference limit. Statistics could not be computed because this condition was absent/prevalent in all participants. Baseline characteristics and exercise test performance, total and split for different study groups %Hrmax, percentage of expected maximal heart rate; BMI, body mass index; CV, cardiovascular; HR, heart rate; hs-cTnT, high-sensitive cardiac troponin T; LoD, limit of detection; Maximal W/kg, maximal workload per kilogram of body weight; RPE, rating of perceived exertion scale (6 = very, very light–20 = maximal exertion); URL, 99% upper reference limit. Statistics could not be computed because this condition was absent/prevalent in all participants. Baseline hs-cTnT concentrations did not differ between the COVID-19 [6.6 (5.3–7.9) ng/L] and control group [7.5 (5.9–9.9) ng/L, P = 0.15]. High-sensi

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.